Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001210988 | SCV001382508 | likely benign | Deafness-lymphedema-leukemia syndrome; Monocytopenia with susceptibility to infections | 2024-05-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004978108 | SCV005596879 | uncertain significance | Inborn genetic diseases | 2024-11-18 | criteria provided, single submitter | clinical testing | The p.S227N variant (also known as c.680G>A), located in coding exon 2 of the GATA2 gene, results from a G to A substitution at nucleotide position 680. The serine at codon 227 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |